Stability of generic brands of meropenem reconstituted in isotonic saline

Minerva Anestesiologica

Volumn 81, Issue 3, 2015, Pages 283-287

  Carlier, M ^a,b   Stove, V ^b   Verstraete, A G ^a,b   De Waele, J J ^b  

^a GHENT UNIVERSITY   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Anti bacterial agents; Meropenem; Polypropylene; Sodium chloride

Indexed keywords

ISOTONIC SOLUTION; MEROPENEM; POLYPROPYLENE; SODIUM CHLORIDE; ANTIINFECTIVE AGENT; THIENAMYCIN DERIVATIVE;

ANALYTIC METHOD; AQUEOUS SOLUTION; ARTICLE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONCENTRATION PROCESS; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG POTENCY; DRUG STABILITY; DRUG STORAGE; DRUG SYNTHESIS; HUMAN; SEPARATION TECHNIQUE; SYRINGE; DRUG FORMULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

ANTI-BACTERIAL AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG COMPOUNDING; DRUG STABILITY; DRUG STORAGE; ISOTONIC SOLUTIONS; SODIUM CHLORIDE; SYRINGES; THIENAMYCINS;

EID: 84930002172     PISSN: 03759393     EISSN: 18271596     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Falagas ME, Tansarli GS, Ikawa K, Vardakas KZ. Clinical outcomes with extended or continuous versus short-term intravenous infusion of carbapenems and piperacillin/tazobactam: a systematic review and meta-analysis. Clin Infect Dis 2013;56:272-82.
2. Dulhunty JM, Roberts JA, Davis JS, Webb SA, Bellomo R, Gomersall C et al. Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial. Clin Infect Dis 2013;56:236-44.
3. Lodise TP, Lomaestro B, Drusano GL. Piperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategy. Clin Infect Dis 2007;44:357-63.
4. Viaene E, Chanteux H, Servais H, Mingeot-Leclercq MP, Tulkens PM. Comparative stability studies of antipseudomonal beta-lactams for potential administration through portable elastomeric pumps (home therapy for cystic fibrosis patients) and motor-operated syringes (intensive care units). Antimicrob Agents Chemother 2002;46:2327-32.
5. Berthoin K, Le Duff CS, Marchand-Brynaert J, Carryn S, Tulkens PM. Stability of meropenem and doripenem solutions for administration by continuous infusion. J Antimicrob Chemother 2010;65:1073-5.
6. Keel RA, Sutherland CA, Crandon JL, Nicolau DP. Stability of doripenem, imipenem and meropenem at elevated room temperatures. Int J Antimicro Ag 2011;37:184-5.
7. Kuti JL, Nightingale CH, Knauft RF, Nicolau DP. Pharmacokinetic properties and stability of continuous-infusion meropenem in adults with cystic fibrosis. Clin Ther 2004;26:493-501.
8. Smith DL, Bauer SA, Nicolau DP. Stability of meropenem in polyvinyl chloride bags and an elastomeric infusion device. Am J Health Syst Pharm 2004;61:1682-5.
9. Jaruratanasirikul S, Sriwiriyajan S. Stability of meropenem in normal saline solution after storage at room temperature. Southeast Asian J Trop Med Public Health 2003;34:627-9.
10. Mastoraki E, Michalopoulos A, Kriaras I, Mouchtouri E, Falagas ME, Karatza D et al. Incidence of postoperative infections in patients undergoing coronary artery bypass grafting surgery receiving antimicrobial prophylaxis with original and generic cefuroxime. J Infect 2008;56:35-9.
11. Carlier M, Stove V, Roberts JA, Van de Velde E, De Waele JJ, Verstraete AG. Quantification of seven β-lactam antibiotics and two β-lactamase inhibitors in human plasma using a validated UPLC-MS/MS method. Int J Antimicrob Agents 2012;40:416-22.
12. Franceschi L, Cojutti P, Baraldo M, Pea F. Stability of generic meropenem solutions for administration by continuous infusion at normal and elevated temperatures. Therapeutic Drug Monitoring 2014;Publish Ahead of Print:10.1097/FTD.0000000000000054.
13. Ong CT, Tessier PR, Li C, Nightingale CH, Nicolau DP. Comparative in vivo efficacy of meropenem, imipenem, and cefepime against Pseudomonas aeruginosa expressing MexA-MexB-OprM efflux pumps. Diagn Micr Infec Dis 2007;57:153-61.
14. Li C, Du X, Kuti JL, Nicolau DP. Clinical Pharmacodynamics of meropenem in patients with lower respiratory tract infections. Antimicrob Agents Chemother 2007;51:1725-30.